Home » Medical Devices » Egypt Peripheral Vascular Devices Market

Egypt Peripheral Vascular Devices Market By Type (Angioplasty Balloons, Angioplasty Stents, Catheters, Guidewires, Others); By End-user (Hospitals, Ambulatory Surgical Centers, Specialty Clinics) – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Price: $2699

Published: | Report ID: 68818 | Report Format : PDF
REPORT ATTRIBUTE DETAILS
Historical Period 2019-2022
Base Year 2023
Forecast Period 2024-2032
Egypt Peripheral Vascular Devices Market Size 2023 USD 37.49 million
Egypt Peripheral Vascular Devices Market, CAGR 3.15%
Egypt Peripheral Vascular Devices Market Size 2032 USD 48.04 million

Market Overview

The Egypt Peripheral Vascular Devices Market is projected to grow from USD 37.49 million in 2023 to USD 48.04 million by 2032, at a compound annual growth rate (CAGR) of 3.15%.

The Egypt Peripheral Vascular Devices market is driven by the increasing prevalence of peripheral artery diseases (PAD) and a growing aging population, which are fueling the demand for advanced treatment solutions. Additionally, the rising awareness about vascular health and the availability of innovative devices, such as drug-coated balloons and stents, are contributing to market growth. Technological advancements, including minimally invasive procedures and enhanced imaging techniques, are improving treatment outcomes and expanding the adoption of peripheral vascular devices. Furthermore, the supportive government initiatives and investments in healthcare infrastructure are creating favorable conditions for market expansion. As healthcare standards improve, the demand for high-quality, cost-effective vascular solutions is expected to rise, with an emphasis on improving patient quality of life and reducing healthcare costs. The market is also witnessing an increasing trend toward outpatient treatments and early detection, driving further growth in the peripheral vascular devices segment.

The Egypt Peripheral Vascular Devices market is primarily concentrated in major metropolitan areas, with Cairo and Alexandria being the key hubs for advanced medical technologies and healthcare infrastructure. These regions have a high demand for peripheral vascular devices due to their large healthcare facilities and growing patient populations. The Suez Canal Region and Upper Egypt are emerging markets, with increasing investments in healthcare infrastructure and rising adoption of advanced medical devices. Key players in the market include global and regional companies such as Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, and Terumo Corporation, which provide a range of innovative devices like angioplasty balloons, stents, and catheters. These companies are expanding their presence in Egypt, driven by the growing demand for effective treatment solutions for peripheral artery diseases. Additionally, local players are increasingly entering the market, providing competition and helping to drive further innovation and accessibility.

Design Element 2

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

CTA Design Element 3

Market Insights

  • The Egypt Peripheral Vascular Devices market is projected to grow from USD 37.49 million in 2023 to USD 48.04 million by 2032, with a CAGR of 3.15%.
  • The increasing prevalence of peripheral artery diseases (PAD) is driving the demand for advanced vascular devices in Egypt.
  • Technological advancements, including drug-coated balloons and bioresorbable stents, are improving treatment outcomes and driving market growth.
  • A shift toward minimally invasive procedures is influencing the adoption of peripheral vascular devices in Egypt.
  • High device costs and limited healthcare infrastructure in rural areas pose challenges to market growth.
  • Cairo and Alexandria are the primary regions driving the market, with the Suez Canal Region and Upper Egypt witnessing steady growth.
  • Key players in the market include Medtronic plc, Boston Scientific Corporation, and Abbott Laboratories, who are expanding their presence in Egypt to meet rising demand.

Market Drivers

Aging Population and Changing Lifestyle

Egypt’s rapidly aging population, coupled with lifestyle changes such as poor diet, lack of exercise, and rising tobacco use, is contributing to a higher risk of vascular diseases. For instance, Egypt is experiencing a significant demographic transition, with the population aged 60 and above expected to more than double from 8.4 million in 2020 to 22 million by 2050. As the population ages, the number of individuals requiring peripheral vascular devices increases. Elderly individuals are particularly susceptible to conditions like PAD, and this demographic is expected to grow significantly in the coming years, further fueling the demand for peripheral vascular interventions and devices.

Government Support and Healthcare Investments

The Egyptian government’s investment in healthcare infrastructure and initiatives to improve medical access are creating a more favorable environment for the growth of the peripheral vascular devices market. For instance, the Ministry of Planning and Economic Development reported that the 2023/24 plan aims to allocate an estimated total investment of EGP 75 billion in health services. Public health policies focusing on improving healthcare access, along with increasing awareness of vascular health, contribute to greater demand for advanced medical solutions. These efforts are boosting both the supply and adoption of peripheral vascular devices, supporting the market’s expansion and providing better care options for Egyptian patients.

Rising Prevalence of Peripheral Artery Diseases (PAD)

The increasing incidence of Peripheral Artery Diseases (PAD) in Egypt is a significant driver of growth in the peripheral vascular devices market. PAD is a major health concern, particularly among the aging population, leading to a surge in demand for diagnostic and therapeutic devices. As more people are diagnosed with PAD, the need for advanced treatments, including stents, balloons, and grafts, rises. This trend is contributing to the expansion of the market as healthcare professionals focus on improving patient outcomes through better vascular treatments.

Technological Advancements in Peripheral Vascular Devices

Technological advancements in peripheral vascular devices are revolutionizing the treatment landscape in Egypt. New innovations, such as drug-coated balloons, self-expanding stents, and bioresorbable scaffolds, offer more effective and minimally invasive treatment options. These technologies enable faster recovery times, fewer complications, and improved long-term outcomes for patients. As these devices become more widely available, healthcare providers are increasingly adopting them, which in turn drives the growth of the market.

Market Trends

Increased Focus on Patient-Centered Care

There is a growing trend towards patient-centered care in the healthcare industry, including in the treatment of peripheral vascular diseases. Patients are increasingly seeking less invasive and more effective treatment options that focus on improving their quality of life. For example, the Egypt Healthcare Authority’s “Patient-Centered Care” project, in collaboration with the Japan International Cooperation Agency (JICA), aims to enhance patient satisfaction and healthcare efficiency through tailored treatment plans. This shift is driving the demand for peripheral vascular devices that offer better outcomes, shorter hospital stays, and quicker return to daily activities. The market is seeing the rise of advanced devices that are designed to deliver tailored solutions for individual patient needs, further enhancing patient satisfaction and healthcare efficiency.

Shift Towards Minimally Invasive Procedures

One of the prominent trends in the Egypt Peripheral Vascular Devices market is the growing preference for minimally invasive procedures. Advances in catheter-based technologies and endovascular techniques have made it possible to treat peripheral artery diseases with smaller incisions, reducing recovery time and improving patient outcomes. These procedures are less traumatic than traditional surgeries, leading to faster recovery and a reduced risk of complications. The trend toward minimally invasive treatments is expected to continue as healthcare providers aim to provide more effective and patient-friendly solutions.

Rise in Outpatient and Ambulatory Care

The Egyptian healthcare sector is witnessing a shift toward outpatient and ambulatory care, which is influencing the demand for peripheral vascular devices. With advancements in technology, procedures that once required hospitalization can now be performed on an outpatient basis, reducing healthcare costs and improving patient convenience. This trend is particularly evident in the treatment of peripheral artery diseases, where many procedures can now be performed in outpatient settings. The increasing preference for outpatient care is encouraging the development and adoption of compact, efficient, and cost-effective vascular devices.

Growing Adoption of Drug-Eluting Technologies

Another key trend in the Egypt Peripheral Vascular Devices market is the growing adoption of drug-eluting technologies. Devices such as drug-coated balloons and drug-eluting stents are becoming increasingly popular due to their ability to reduce the risk of restenosis (re-narrowing of arteries) and improve long-term outcomes. These technologies are particularly beneficial in treating complex peripheral vascular diseases, where traditional devices may fall short. As these advanced technologies become more accessible, healthcare providers are increasingly incorporating them into their treatment protocols, further driving market growth.

Market Challenges Analysis

High Cost of Advanced Devices

One of the significant challenges facing the Egypt Peripheral Vascular Devices market is the high cost of advanced medical devices. The latest innovations, such as drug-eluting stents and bioresorbable scaffolds, are often expensive, which can limit their accessibility in both public and private healthcare sectors. For instance, the average cost of a drug-eluting stent in Egypt can range from EGP 10,000 to EGP 15,000. While these devices offer improved outcomes and reduced complications, their cost can be prohibitive for many patients, especially in a developing economy like Egypt. This economic barrier affects both patients’ ability to afford treatment and healthcare providers’ capacity to invest in advanced technologies. As a result, there is a growing need for cost-effective alternatives and better reimbursement policies to ensure that these devices are accessible to a wider population.

Limited Healthcare Infrastructure and Skilled Professionals

Another key challenge is the limited healthcare infrastructure and shortage of skilled professionals in the country. Despite significant improvements in healthcare access, many healthcare facilities still face challenges in offering cutting-edge treatments due to outdated equipment and insufficient training for medical professionals. For instance, according to the Central Agency for Public Mobilization and Statistics (CAPMAS), there were 100,742 physicians in the public sector and 30,138 in the private sector as of 2021. This gap in skilled personnel can lead to underutilization of advanced peripheral vascular devices and hinder the adoption of new treatment options. Additionally, in rural areas, access to specialized vascular care remains limited, which affects the overall market growth. Overcoming these challenges requires further investment in healthcare infrastructure, ongoing professional training, and expanding access to specialized care across the country.

Market Opportunities

Expansion of Healthcare Access and Infrastructure

One of the key opportunities in the Egypt Peripheral Vascular Devices market is the expansion of healthcare access and infrastructure. The Egyptian government has been focusing on improving healthcare services across the country, particularly in underserved rural areas. With this increased investment, there is a growing opportunity for peripheral vascular device manufacturers to tap into new markets and reach a larger population. As healthcare facilities upgrade and expand, there is a greater potential for the adoption of advanced medical technologies, including peripheral vascular devices. These efforts could lead to improved patient outcomes and enhanced access to life-saving treatments, driving market growth in the coming years.

Growing Demand for Early Diagnosis and Preventive Care

There is a rising trend towards early diagnosis and preventive care in Egypt, creating significant opportunities for the peripheral vascular devices market. With increased awareness of vascular health and the importance of early intervention, more patients are seeking diagnostic screenings for conditions like peripheral artery disease. This growing demand for early diagnosis presents an opportunity for the market to expand, as healthcare providers seek innovative, cost-effective devices to detect and treat vascular conditions at an early stage. Additionally, the focus on preventive care allows for the integration of non-invasive and minimally invasive peripheral vascular devices, which are expected to gain traction as part of broader efforts to improve patient care and reduce healthcare costs.

Market Segmentation Analysis:

By Type:

The Egypt Peripheral Vascular Devices market is primarily segmented by type, with key categories including angioplasty balloons, angioplasty stents, catheters, guidewires, and others. Among these, angioplasty balloons hold a significant share due to their use in minimally invasive procedures to treat peripheral artery diseases (PAD). Angioplasty stents are also critical in maintaining vascular patency, driving their demand in the market. Catheters and guidewires are essential tools in various diagnostic and therapeutic procedures, making them indispensable in the treatment of peripheral vascular diseases. The “others” category includes ancillary devices and accessories that support the primary treatments, further expanding the market. The continued advancements in these devices, such as drug-coated balloons and bioresorbable stents, are expected to boost the adoption of these technologies. As peripheral vascular disease diagnoses increase, the demand for these devices, especially in complex cases, is anticipated to grow, further shaping the market dynamics in Egypt.

By End-user:
In terms of end-users, the Egypt Peripheral Vascular Devices market is categorized into hospitals, ambulatory surgical centers, and specialty clinics. Hospitals represent the largest segment due to their extensive infrastructure and ability to handle complex surgeries and vascular interventions. Ambulatory surgical centers are gaining popularity for their cost-effectiveness and shorter patient recovery times, particularly for less invasive procedures. As healthcare delivery moves toward outpatient care, these centers are becoming increasingly important in the market. Specialty clinics, which focus on vascular health, also contribute to the market by offering specialized treatments for peripheral vascular diseases. With the rising preference for outpatient treatments and early interventions, these end-user segments are expected to see steady growth, driving the demand for peripheral vascular devices across various healthcare settings in Egypt.

Segments:

Based on Type:

  • Angioplasty Balloons
  • Angioplasty Stents
  • Catheters
  • Guidewires
  • Others

Based on End-user:

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics

Based on the Geography:

  • Cairo
  • Alexandria
  • Suez Canal Region
  • Upper Egypt

Regional Analysis

Cairo

Cairo dominates the Egypt Peripheral Vascular Devices market with a significant market share of 45%. As the capital and largest city, Cairo is home to the most advanced healthcare facilities, attracting both local and international patients. The city’s healthcare infrastructure, including a high number of specialized hospitals and vascular centers, enables the widespread use of peripheral vascular devices. Additionally, Cairo benefits from its role as a hub for medical research, education, and technological advancements, leading to greater adoption of cutting-edge medical treatments. The growing awareness of vascular diseases and rising incidence of peripheral artery diseases (PAD) in Cairo further fuel demand for advanced devices such as angioplasty balloons, stents, and catheters.

Alexandria

Alexandria holds a market share of approximately 20%, making it the second-largest region in Egypt for peripheral vascular devices. The city’s expanding healthcare infrastructure, including specialized clinics and hospitals, is driving the adoption of advanced medical devices. Alexandria’s proximity to the Mediterranean also encourages medical tourism, with patients traveling from neighboring regions for high-quality vascular treatments. The growing demand for both diagnostic and therapeutic peripheral vascular devices is supported by increased awareness campaigns and government initiatives focusing on improving healthcare services. The region is poised for significant growth in the coming years as healthcare accessibility continues to improve.

Suez Canal Region and Upper Egypt

The Suez Canal Region and Upper Egypt represent emerging markets in the peripheral vascular devices sector, with respective market shares of 15% and 10%. Both regions face challenges related to healthcare infrastructure but are experiencing gradual improvements. The Suez Canal Region benefits from its strategic location, which facilitates medical tourism and increases demand for advanced healthcare solutions. Upper Egypt, though historically underserved, is seeing increased investments in healthcare infrastructure, spurring growth in the adoption of peripheral vascular devices. These regions are witnessing a shift towards more accessible outpatient care, helping drive the market for minimally invasive vascular devices. With ongoing government investments and healthcare reforms, both regions are expected to experience steady market growth over the next decade.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Key Player Analysis

  • Medtronic plc
  • Boston Scientific Corporation
  • Abbott Laboratories
  • Cook Medical
  • Terumo Corporation
  • Becton, Dickinson and Company
  • Cardinal Health
  • Biotronik SE & Co. KG
  • AngioDynamics, Inc.
  • L. Gore & Associates, Inc.

Competitive Analysis

The competitive landscape of the Egypt Peripheral Vascular Devices market is shaped by both global and regional players offering a wide range of innovative solutions. Leading companies such as Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, Cook Medical, Terumo Corporation, Becton, Dickinson and Company, Cardinal Health, Biotronik SE & Co. KG, AngioDynamics, Inc., and W. L. Gore & Associates, Inc. dominate the market with their advanced technologies in angioplasty balloons, stents, catheters, and guidewires. For instance, the World Health Organization reports that over 1 billion individuals globally are diagnosed with obesity, including 650 million adults. Companies in this market focus on providing advanced, minimally invasive solutions, such as angioplasty balloons, stents, catheters, and guidewires, which are in high demand due to the growing prevalence of peripheral artery diseases. The competition is driven by continuous advancements in technology, with players focusing on improving treatment outcomes, reducing complications, and enhancing the patient experience. Additionally, companies are investing in product diversification, including drug-eluting devices and bioresorbable stents, which offer improved long-term efficacy and reduced restenosis rates. This innovation is helping to drive the adoption of new devices. Pricing strategies also play a crucial role in maintaining competitiveness, with both global and regional players tailoring their offerings to meet the needs of various healthcare providers, from large hospitals to smaller specialty clinics. The increasing shift toward outpatient care and minimally invasive procedures is further driving market dynamics, with competitors focusing on providing cost-effective solutions that cater to the growing demand for less invasive treatment options. As the healthcare infrastructure in Egypt improves, competition is expected to intensify, with companies striving to offer comprehensive, accessible, and effective peripheral vascular treatment solutions.

Recent Developments

  • In December 2024, Terumo Interventional Systems launched the R2P™ NaviCross® peripheral support catheter in the U.S. This catheter is designed for enhanced performance in radial-to-peripheral procedures, addressing the need for advanced tools in treating PAD and critical limb ischemia.
  • In October 2024, BD was highlighted as a key player in the peripheral vascular devices market forecast report. While specific recent product launches were not detailed, BD’s ongoing commitment to R&D and innovation positions it strongly within this competitive landscape.
  • In June 2023, Cook Medical announced new size options for its Advance Serenity PTA Balloon Catheter, used for treating peripheral artery disease (PAD).
  • In June 2023, Biotronik launched the Oscar multifunctional peripheral catheter, designed for dilation of stenotic segments in peripheral vessels. The device features user-adjustable components and aims to improve procedural efficiency in treating peripheral arterial disease.

Market Concentration & Characteristics

The market concentration of Egypt’s Peripheral Vascular Devices sector is moderately fragmented, with a mix of global leaders and regional players. Large multinational companies, with advanced technological capabilities and extensive product portfolios, dominate a significant portion of the market. These players focus on high-quality, innovative devices such as angioplasty balloons, stents, catheters, and guidewires. While multinational companies hold a competitive edge due to their research and development capabilities, regional players are also emerging, offering cost-effective solutions tailored to local market needs. The entry of these regional companies is contributing to increasing market competition, which is expected to drive product innovation and improve affordability. The market characteristics of Egypt’s peripheral vascular devices are shaped by a growing demand for minimally invasive procedures and a shift toward outpatient care. This trend is encouraging the adoption of devices that offer shorter recovery times and reduced complications. Additionally, there is an increasing focus on improving treatment outcomes, with innovations such as drug-eluting devices and bioresorbable stents gaining traction. With healthcare investments on the rise and the expanding awareness of vascular diseases, Egypt’s market for peripheral vascular devices is expected to grow steadily. Companies are targeting both the private and public healthcare sectors, as well as investing in enhancing product accessibility and affordability to reach a broader patient base.

Report Coverage

The research report offers an in-depth analysis based on Type, End-user and Geography. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.

Future Outlook

  1. The Egypt Peripheral Vascular Devices market is expected to grow steadily due to increasing healthcare investments and improving infrastructure.
  2. Rising awareness about peripheral artery diseases will drive the demand for advanced vascular treatment solutions.
  3. Technological advancements in devices, such as drug-coated balloons and bioresorbable stents, will enhance treatment efficacy and adoption.
  4. A shift toward minimally invasive and outpatient procedures will lead to higher demand for peripheral vascular devices.
  5. The expansion of healthcare facilities, especially in underserved regions like Upper Egypt, will support market growth.
  6. Government initiatives to improve healthcare access and affordability will stimulate the adoption of vascular devices.
  7. The emergence of regional players will increase competition and drive innovation in the market.
  8. Increasing cases of diabetes and hypertension in Egypt will contribute to the growing prevalence of peripheral artery diseases.
  9. The focus on cost-effective healthcare solutions will lead to the development of affordable vascular devices.
  10. Continuous research and development efforts will result in the introduction of new, advanced technologies, further expanding the market.

CHAPTER NO. 1 : INTRODUCTION 19

1.1.1. Report Description 19

Purpose of the Report 19

USP & Key Offerings 19

1.1.2. Key Benefits for Stakeholders 19

1.1.3. Target Audience 20

1.1.4. Report Scope 20

CHAPTER NO. 2 : EXECUTIVE SUMMARY 21

2.1. Peripheral Vascular Devices Market Snapshot 21

2.1.1. Egypt Peripheral Vascular Devices Market, 2018 – 2032 (USD Million) 22

CHAPTER NO. 3 : GEOPOLITICAL CRISIS IMPACT ANALYSIS 23

3.1. Russia-Ukraine and Israel-Palestine War Impacts 23

CHAPTER NO. 4 : PERIPHERAL VASCULAR DEVICES MARKET – INDUSTRY ANALYSIS 24

4.1. Introduction 24

4.2. Market Drivers 25

4.2.1. Increasing prevalence of peripheral artery disease and other vascular conditions 25

4.2.2. Technological advancements in minimally invasive procedures 26

4.3. Market Restraints 27

4.3.1. High cost of peripheral vascular devices and associated procedures 27

4.4. Market Opportunities 28

4.4.1. Growing demand for peripheral vascular devices in emerging economies 28

4.5. Porter’s Five Forces Analysis 29

4.6. Buying Criteria 30

CHAPTER NO. 5 : IMPORT EXPORT ANALYSIS 31

5.1. Import Analysis by Egypt 31

5.1.1. Egypt Peripheral Vascular Devices Market Import Volume/Revenue, By Egypt, 2018 – 2023 31

5.2. Export Analysis by Egypt 32

5.2.1. Egypt Peripheral Vascular Devices Market Export Volume/Revenue, By Egypt, 2018 – 2023 32

CHAPTER NO. 6 : DEMAND SUPPLY ANALYSIS 33

6.1. Demand Analysis by Egypt 33

6.1.1. Egypt Peripheral Vascular Devices Market Demand Volume/Revenue, By Egypt, 2018 – 2023 33

6.2. Supply Analysis by Egypt 34

6.2.1. Egypt Peripheral Vascular Devices Market Supply Volume/Revenue, By Egypt, 2018 – 2023 34

CHAPTER NO. 7 : PRODUCTION ANALYSIS 35

7.1. Production Analysis by Egypt 35

7.1.1. Egypt Peripheral Vascular Devices Market Production Volume/Revenue, By Egypt, 2018 – 2023 35

CHAPTER NO. 8 : PRICE ANALYSIS 36

8.1. Price Analysis by Type 36

8.1.1. Egypt Peripheral Vascular Devices Market Price, By Type, 2018 – 2023 36

8.1.2. Egypt Type Market Price, By Type, 2018 – 2023 36

CHAPTER NO. 9 : RAW MATERIALS ANALYSIS 37

9.1. Key Raw Materials and Suppliers 37

9.2. Key Raw Materials Price Trend 37

CHAPTER NO. 10 : MANUFACTURING COST ANALYSIS 38

10.1. Manufacturing Cost Analysis 38

10.2. Manufacturing Process 38

CHAPTER NO. 11 : ANALYSIS COMPETITIVE LANDSCAPE 39

11.1. Company Market Share Analysis – 2023 39

11.2. Value Chain Analysis 39

11.2.1. Egypt Peripheral Vascular Devices Market: Company Market Share, by Volume, 2023 40

11.2.2. Egypt Peripheral Vascular Devices Market: Company Market Share, by Revenue, 2023 41

11.2.3. Egypt Peripheral Vascular Devices Market: Top 6 Company Market Share, by Revenue, 2023 41

11.2.4. Egypt Peripheral Vascular Devices Market: Top 3 Company Market Share, by Revenue, 2023 42

11.3. Egypt Peripheral Vascular Devices Market Company Volume Market Share, 2023 43

11.4. Egypt Peripheral Vascular Devices Market Company Revenue Market Share, 2023 44

11.5. Company Assessment Metrics, 2023 44

11.5.1. Stars 44

11.5.2. Emerging Leaders 44

11.5.3. Pervasive Players 44

11.5.4. Participants 44

11.6. Start-ups /SMEs Assessment Metrics, 2023 44

11.6.1. Progressive Companies 44

11.6.2. Responsive Companies 45

11.6.3. Dynamic Companies 45

11.6.4. Starting Blocks 45

11.7. Strategic Developments 46

11.7.1. Acquisitions & Mergers 46

New Product Launch 46

Egypt Expansion 46

11.8. Key Players Product Matrix 47

CHAPTER NO. 12 : PESTEL & ADJACENT MARKET ANALYSIS 48

12.1. PESTEL 48

12.1.1. Political Factors 48

12.1.2. Economic Factors 48

12.1.3. Social Factors 48

12.1.4. Technological Factors 48

12.1.5. Environmental Factors 48

12.1.6. Legal Factors 48

12.2. Adjacent Market Analysis 48

CHAPTER NO. 13 : PERIPHERAL VASCULAR DEVICES MARKET – BY TYPE SEGMENT ANALYSIS 49

13.1. Peripheral Vascular Devices Market Overview, by Type Segment 49

13.1.1. Peripheral Vascular Devices Market Revenue Share, By Type, 2023 & 2032 50

13.1.2. Peripheral Vascular Devices Market Attractiveness Analysis, By Type 51

13.1.3. Incremental Revenue Growth Opportunity, by Type, 2024 – 2032 51

13.1.4. Peripheral Vascular Devices Market Revenue, By Type, 2018, 2023, 2027 & 2032 52

13.2. Angioplasty Balloons 53

13.3. Angioplasty Stents 54

13.4. Catheters 55

13.5. Guidewires 56

13.6. Others 57

CHAPTER NO. 14 : PERIPHERAL VASCULAR DEVICES MARKET – BY END-USER SEGMENT ANALYSIS 58

14.1. Peripheral Vascular Devices Market Overview, by End-user Segment 58

14.1.1. Peripheral Vascular Devices Market Revenue Share, By End-user, 2023 & 2032 59

14.1.2. Peripheral Vascular Devices Market Attractiveness Analysis, By End-user 60

14.1.3. Incremental Revenue Growth Opportunity, by End-user, 2024 – 2032 60

14.1.4. Peripheral Vascular Devices Market Revenue, By End-user, 2018, 2023, 2027 & 2032 61

14.2. Hospitals 62

14.3. Ambulatory Surgical Centers 63

14.4. Specialty Clinics 64

CHAPTER NO. 15 : PERIPHERAL VASCULAR DEVICES MARKET – EGYPT ANALYSIS 65

15.1. Type 65

15.1.1. Egypt Peripheral Vascular Devices Market Revenue, By Type, 2018 – 2023 (USD Million) 65

15.2. Egypt Peripheral Vascular Devices Market Revenue, By Type, 2024 – 2032 (USD Million) 65

15.3. End-user 66

15.3.1. Egypt Peripheral Vascular Devices Market Revenue, By End-user, 2018 – 2023 (USD Million) 66

15.3.2. Egypt Peripheral Vascular Devices Market Revenue, By End-user, 2024 – 2032 (USD Million) 66

CHAPTER NO. 16 : COMPANY PROFILES 67

16.1. Medtronic plc 67

16.1.1. Company Overview 67

16.1.2. Product Portfolio 67

16.1.3. Swot Analysis 67

16.1.4. Business Strategy 68

16.1.5. Financial Overview 68

16.2. Boston Scientific Corporation 69

16.3. Abbott Laboratories 69

16.4. Cook Medical 69

16.5. Terumo Corporation 69

16.6. Becton, Dickinson and Company 69

16.7. Cardinal Health 69

16.8. Biotronik SE & Co. KG 69

16.9. AngioDynamics, Inc. 69

16.10. W. L. Gore & Associates, Inc. 69

List of Figures

FIG NO. 1. Egypt Peripheral Vascular Devices Market Revenue, 2018 – 2032 (USD Million) 22

FIG NO. 2. Porter’s Five Forces Analysis for Egypt Peripheral Vascular Devices Market 29

FIG NO. 3. Egypt Peripheral Vascular Devices Market Import Volume/Revenue, By Egypt, 2018 – 2023 31

FIG NO. 4. Egypt Peripheral Vascular Devices Market Export Volume/Revenue, By Egypt, 2018 – 2023 32

FIG NO. 5. Egypt Peripheral Vascular Devices Market Demand Volume/Revenue, By Egypt, 2018 – 2023 33

FIG NO. 6. Egypt Peripheral Vascular Devices Market Supply Volume/Revenue, By Egypt, 2018 – 2023 34

FIG NO. 7. Egypt Peripheral Vascular Devices Market Production Volume/Revenue, By Egypt, 2018 – 2023 35

FIG NO. 8. Egypt Peripheral Vascular Devices Market Price, By Type, 2018 – 2023 36

FIG NO. 9. Raw Materials Price Trend Analysis, 2018 – 2023 37

FIG NO. 10. Manufacturing Cost Analysis 38

FIG NO. 11. Manufacturing Process 38

FIG NO. 12. Value Chain Analysis for Egypt Peripheral Vascular Devices Market 39

FIG NO. 13. Company Share Analysis, 2023 40

FIG NO. 14. Company Share Analysis, 2023 41

FIG NO. 15. Company Share Analysis, 2023 41

FIG NO. 16. Company Share Analysis, 2023 42

FIG NO. 17. Peripheral Vascular Devices Market – Company Volume  Market Share, 2023 43

FIG NO. 18. Peripheral Vascular Devices Market – Company Revenue Market Share, 2023 44

FIG NO. 19. Peripheral Vascular Devices Market Revenue Share, By Type, 2023 & 2032 50

FIG NO. 20. Market Attractiveness Analysis, By Type 51

FIG NO. 21. Incremental Revenue Growth Opportunity by Type, 2024 – 2032 51

FIG NO. 22. Peripheral Vascular Devices Market Revenue, By Type, 2018, 2023, 2027 & 2032 52

FIG NO. 23. Egypt Peripheral Vascular Devices Market for Angioplasty Balloons, Revenue (USD Million) 2018 – 2032 53

FIG NO. 24. Egypt Peripheral Vascular Devices Market for Angioplasty Stents, Revenue (USD Million) 2018 – 2032 54

FIG NO. 25. Egypt Peripheral Vascular Devices Market for Catheters, Revenue (USD Million) 2018 – 2032 55

FIG NO. 26. Egypt Peripheral Vascular Devices Market for Guidewires, Revenue (USD Million) 2018 – 2032 56

FIG NO. 27. Egypt Peripheral Vascular Devices Market for Others, Revenue (USD Million) 2018 – 2032 57

FIG NO. 28. Peripheral Vascular Devices Market Revenue Share, By End-user, 2023 & 2032 59

FIG NO. 29. Market Attractiveness Analysis, By End-user 60

FIG NO. 30. Incremental Revenue Growth Opportunity by End-user, 2024 – 2032 60

FIG NO. 31. Peripheral Vascular Devices Market Revenue, By End-user, 2018, 2023, 2027 & 2032 61

FIG NO. 32. Egypt Peripheral Vascular Devices Market for Hospitals, Revenue (USD Million) 2018 – 2032 62

FIG NO. 33. Egypt Peripheral Vascular Devices Market for Ambulatory Surgical Centers, Revenue (USD Million) 2018 – 2032 63

FIG NO. 34. Egypt Peripheral Vascular Devices Market for Specialty Clinics, Revenue (USD Million) 2018 – 2032 64

List of Tables

TABLE NO. 1. : Egypt Peripheral Vascular Devices Market: Snapshot 21

TABLE NO. 2. : Drivers for the Peripheral Vascular Devices Market: Impact Analysis 25

TABLE NO. 3. : Restraints for the Peripheral Vascular Devices Market: Impact Analysis 27

TABLE NO. 4. : Egypt Peripheral Vascular Devices Market Revenue, By Type, 2018 – 2023 36

TABLE NO. 5. : Key Raw Materials & Suppliers 37

TABLE NO. 6. : Egypt Peripheral Vascular Devices Market Revenue, By Type, 2018 – 2023 (USD Million) 65

TABLE NO. 7. : Egypt Peripheral Vascular Devices Market Revenue, By Type, 2024 – 2032 (USD Million) 65

TABLE NO. 8. : Egypt Peripheral Vascular Devices Market Revenue, By End-user, 2018 – 2023 (USD Million) 66

TABLE NO. 9. : Egypt Peripheral Vascular Devices Market Revenue, By End-user, 2024 – 2032 (USD Million) 66

 

Frequently Asked Questions

What is the current size of the Egypt Peripheral Vascular Devices market?

The Egypt Peripheral Vascular Devices market was valued at USD 37.49 million in 2023 and is projected to grow to USD 48.04 million by 2032, with a compound annual growth rate (CAGR) of 3.15%.

What factors are driving the growth of the Egypt Peripheral Vascular Devices market?

The market’s growth is driven by the increasing prevalence of peripheral artery diseases (PAD), a growing aging population, rising awareness of vascular health, and technological advancements such as drug-coated balloons and bioresorbable stents. Government healthcare investments and a shift toward minimally invasive procedures further support the market’s expansion.

What are the key segments within the Egypt Peripheral Vascular Devices market?

The market is segmented by type into angioplasty balloons, angioplasty stents, catheters, guidewires, and others. By end-user, it includes hospitals, ambulatory surgical centers, and specialty clinics. Geographically, key regions include Cairo, Alexandria, the Suez Canal Region, and Upper Egypt, with Cairo dominating the market due to advanced healthcare infrastructure.

What are some challenges faced by the Egypt Peripheral Vascular Devices market?

Challenges include the high cost of advanced devices such as drug-eluting stents and bioresorbable scaffolds, limited healthcare infrastructure in rural areas, and a shortage of skilled professionals to perform complex procedures. These factors affect accessibility and adoption of advanced vascular devices.

Who are the major players in the Egypt Peripheral Vascular Devices market?

Key players include Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, Cook Medical, Terumo Corporation, Becton, Dickinson and Company, Cardinal Health, Biotronik SE & Co. KG, AngioDynamics, Inc., and W. L. Gore & Associates, Inc. These companies focus on innovation and offer a range of advanced vascular treatment solutions.

Egypt Grid Modernization Market

Published:
Report ID: 75199

Egypt Data Center Uninterruptable Power Supply (UPS) Market

Published:
Report ID: 72409

Egypt Soldier Modernization Market

Published:
Report ID: 71873

Egypt Military Aircraft Modernization Market

Published:
Report ID: 71350

Egypt Peritoneal Dialysis Market

Published:
Report ID: 70798

Egypt Medical Gas and Equipment Market

Published:
Report ID: 70809

Egypt Industry Vertical Modernization Services Market

Published:
Report ID: 70234

Egypt Elevator Modernization Market

Published:
Report ID: 69760

Egypt Mainframe Modernization Services Market

Published:
Report ID: 65927

Endoscopic Vessel Harvesting Systems Market

Published:
Report ID: 4328

South Africa Medical Gas and Equipment Market

Published:
Report ID: 75642

Compliance Monitoring Devices Market

Published:
Report ID: 75564

Continuous Glucose Monitoring Devices Market

Published:
Report ID: 4258

Internal Radiation Therapy Market

Published:
Report ID: 75411

Image Guided Radiotherapy Market

Published:
Report ID: 75382

Flat Panel X-Ray Detectors Market

Published:
Report ID: 74896

Hemostasis Testing Systems Market

Published:
Report ID: 74856

Cardiac Ultrasound Systems Market

Published:
Report ID: 74702

Aesthetic Medical Devices Market

Published:
Report ID: 74587

Italy Diabetes Care Devices Market

Published:
Report ID: 64898

Transplant Monitoring Kits Market

Published:
Report ID: 74464

Purchase Options

The report comes as a view-only PDF document, optimized for individual clients. This version is recommended for personal digital use and does not allow printing.
$2699

To meet the needs of modern corporate teams, our report comes in two formats: a printable PDF and a data-rich Excel sheet. This package is optimized for internal analysis and multi-location access, making it an excellent choice for organizations with distributed workforce.
$3699

The report will be delivered in printable PDF format along with the report’s data Excel sheet. This license offers 100 Free Analyst hours where the client can utilize Credence Research Inc.’s research team. It is highly recommended for organizations seeking to execute short, customized research projects related to the scope of the purchased report.
$5699

Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207


support

24/7 Research Support


sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN